1. P-216Neo-adjuvant Chemo-Radiation for Resectable Esophageal Carcinoma – is Oral Capecitabine Non-Inferior to Paclitaxel – Carboplatin Combination?

    http://dx.doi.org/10.1093/annonc/mdz155.215
  2. JS3-1A case of heart failure after radiation therapy for mediastinum

    http://dx.doi.org/10.1093/annonc/mdz306
  3. Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications

    http://dx.doi.org/10.1093/annonc/mdz140
  4. Rare cancers: from centralized referral to networking

    http://dx.doi.org/10.1093/annonc/mdz146
  5. Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis

    http://dx.doi.org/10.1093/annonc/mdz145
  6. Interactions between direct anticoagulants and chemotherapy

    http://dx.doi.org/10.1093/annonc/mdz137
  7. Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark?

    http://dx.doi.org/10.1093/annonc/mdz166
  8. Hyperprogression during immunotherapy: do we really want to know?

    http://dx.doi.org/10.1093/annonc/mdz184
  9. EL22Recent Development of Treatment Strategy for Early Breast Cancer

    http://dx.doi.org/10.1093/annonc/mdz366
  10. Early-phase clinical drug development of novel agents: a changing paradigm

    http://dx.doi.org/10.1093/annonc/mdz165
Copyright © 2015 0923-7534的搜索结果由GYCC学术搜索提供 - 意见反馈 >>小额捐赠|打赏